Yazıcı, OnurBozkuş, FulsenDemirci, NilgünGülhan, Pınar YıldızCoşkun, Funda2024-07-082024-07-082020-05-182148-3620https://doi.org/10.4103/ejop.ejop_49_20https://eurasianjpulmonol.com/article/75https://hdl.handle.net/11452/43030Caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) is a potentially fatal disease as a global public health issue. Several mechanisms may be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulation caused by SARS-CoV-2. When patients have coagulation disorders, treatment becomes more challenging and mortality rate increases accordingly. The aim of this article is to review the potential mechanisms of coagulopathy in COVID-19 in light of literature data.eninfo:eu-repo/semantics/openAccessSepsisCOVIT-19CoagulopathyDisseminated intravascular coagulationRespiratory systemReview0005786038000146769224, Supplement S10.4103/ejop.ejop_49_20